載入...
Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGVHD
Donor lymphocyte infusion (DLI) is an option for relapsed hematologic malignancies or incomplete chimerism of non-malignant diseases following allogeneic hematopoietic cell transplantation (HCT). We analyzed the incidence of acute graft versus host disease (aGVHD) in patients treated with DLI. From...
Na minha lista:
| 發表在: | Bone Marrow Transplant |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4972636/ https://ncbi.nlm.nih.gov/pubmed/27064686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.63 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|